With this certification, the Smidt Heart Institute becomes the association’s only Comprehensive Hypertension Center in Los Angeles and one of only three in California.
Research shows that patients have better outcomes when they are treated at an accredited center by physicians specialized in the disease.
Hypertension Center physicians also are among the most experienced in specialized care for people with secondary hypertension caused by primary aldosteronism (a disorder of the adrenal glands), pheochromocytoma (an often-benign tumor of the adrenal gland) or renal artery stenosis (blockage of the kidney artery often caused by cholesterol plaque buildup).
Evaluation, testing and treatments for secondary hypertension include hormone testing and analysis, imaging of the adrenal glands and renal arteries, and surgical procedures led by specialty-trained surgeons.
In addition to providing evidence-based treatments, the center also gives patients access to clinical trials studying new pharmacologic and device-based treatment options.
“We are continuously aiming to make further advancements in how we diagnose and treat hypertension, including the most complex cases—which was among the criteria used in evaluating our Hypertension Center’s application for accreditation,” said Natalie Bello, MD, MPH, director of Hypertension Research in the Smidt Heart Institute. “We’re always eager to explore new, more effective options for our patients.”
The American Heart Association regularly updates its accreditation criteria to reflect the latest evidence and guidelines in hypertension care. The process involves thoroughly evaluating a healthcare institution’s practices and protocols. A team of experts, including physicians, researchers, and other healthcare professionals, reviews patient care, staff training, clinical research, community outreach and quality improvement initiatives.
The Smidt Heart Institute is ranked #1 in California and #3 in the nation for Cardiology and Heart Surgery by U.S. News and World Report’s “Best Hospitals 2022-23.”
Read more on the Cedars-Sinai Blog: High Blood Pressure | What Women Need to Know